Additionally, BBR has potential therapeutic effects on AD through different pathological mechanisms, such as lowering Aβ levels, inhibiting the phosphorylation of Tau protein, anti-oxidation, inhibiting the activity of AchE and MAO, and regulating lipids, hypoglycemic. The gene discussed is MAPT; the disease is Alzheimer disease.